-
1
-
-
0023747883
-
Neuroleptic side effects: Acute extrapyramidal syndromes and tardive dyskinesia
-
Casey DE, Keepers GA. Neuroleptic side effects: Acute extrapyramidal syndromes and tardive dyskinesia. Psychopharmacol. Ser. 1988 5 : 74 93.
-
(1988)
Psychopharmacol. Ser.
, vol.5
, pp. 74-93
-
-
Casey, D.E.1
Keepers, G.A.2
-
3
-
-
0030854215
-
Tardive dyskinesia and ethnicity: Review of the literature
-
Swartz JR, Burgoyne K, Smith M, Gadasally R, Ananth J, Ananth K. Tardive dyskinesia and ethnicity: Review of the literature. Ann. Clin. Psychiatry 1997 9 : 53 59.
-
(1997)
Ann. Clin. Psychiatry
, vol.9
, pp. 53-59
-
-
Swartz, J.R.1
Burgoyne, K.2
Smith, M.3
Gadasally, R.4
Ananth, J.5
Ananth, K.6
-
4
-
-
0034036233
-
Association between cytochrome P4502D6 (CYP2D6) genotype, antipsychotic exposure, and abnormal involuntary movement scale (AIMS) score
-
Ellingrod VL, Schultz SK, Arndt S. Association between cytochrome P4502D6 (CYP2D6) genotype, antipsychotic exposure, and abnormal involuntary movement scale (AIMS) score. Psychiatr. Genet. 2000 10 : 9 11.
-
(2000)
Psychiatr. Genet.
, vol.10
, pp. 9-11
-
-
Ellingrod, V.L.1
Schultz, S.K.2
Arndt, S.3
-
5
-
-
0345690100
-
Half a century of antipsychotics and still a central role for dopamine D2 receptors
-
Kapur S, Mamo D. Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003 27 : 1081 1090.
-
(2003)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.27
, pp. 1081-1090
-
-
Kapur, S.1
Mamo, D.2
-
7
-
-
84983724523
-
Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: Role of dopamine transporter
-
Fachinetto R, Villarinho JG, Wagner C et al. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: Role of dopamine transporter. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007 31 : 1478 1486.
-
(2007)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.31
, pp. 1478-1486
-
-
Fachinetto, R.1
Villarinho, J.G.2
Wagner, C.3
-
8
-
-
34548183496
-
Effect of spirulina maxima on the haloperidol induced tardive dyskinesia and oxidative stress in rats
-
Thaakur SR, Jyothi B. Effect of spirulina maxima on the haloperidol induced tardive dyskinesia and oxidative stress in rats. J. Neural. Transm. 2007 114 : 1217 1225.
-
(2007)
J. Neural. Transm.
, vol.114
, pp. 1217-1225
-
-
Thaakur, S.R.1
Jyothi, B.2
-
9
-
-
33750866196
-
Gkycogen Synthase Kinase-3 (GSK-3) in psychiatric diseases and therapeutic interventions
-
Jope RS, Roh MS. Gkycogen Synthase Kinase-3 (GSK-3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets 2006 7 : 1421 1434.
-
(2006)
Curr. Drug Targets
, vol.7
, pp. 1421-1434
-
-
Jope, R.S.1
Roh, M.S.2
-
10
-
-
0034859101
-
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling
-
Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 2001 65 : 391 426.
-
(2001)
Prog. Neurobiol.
, vol.65
, pp. 391-426
-
-
Grimes, C.A.1
Jope, R.S.2
-
11
-
-
0035917848
-
Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia
-
Beasley C, Cotter D, Khan N et al. Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci. Lett. 2001 302 : 117 120.
-
(2001)
Neurosci. Lett.
, vol.302
, pp. 117-120
-
-
Beasley, C.1
Cotter, D.2
Khan, N.3
-
12
-
-
0035476357
-
Low GSK-3 activity in frontal cortex of schizophrenic patients
-
Kozlovsky N, Belmaker RH, Agam G. Low GSK-3 activity in frontal cortex of schizophrenic patients. Schizophr. Res. 2001 52 : 101 105.
-
(2001)
Schizophr. Res.
, vol.52
, pp. 101-105
-
-
Kozlovsky, N.1
Belmaker, R.H.2
Agam, G.3
-
13
-
-
4944253476
-
GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients
-
DOI 10.1016/j.schres.2004.02.020, PII S0920996404000623
-
Nadri C, Dean B, Scarr E, Agam G. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients. Schizophr. Res. 2004 71 : 377 382. (Pubitemid 39330516)
-
(2004)
Schizophrenia Research
, vol.71
, Issue.2-3
, pp. 377-382
-
-
Nadri, C.1
Dean, B.2
Scarr, E.3
Agam, G.4
-
14
-
-
0028866230
-
Neurotrophins and neuronal plasticity
-
Thoenen H. Neurotrophins and neuronal plasticity. Science 1995 270 : 593 598.
-
(1995)
Science
, vol.270
, pp. 593-598
-
-
Thoenen, H.1
-
16
-
-
13844297979
-
Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements
-
Tan YL, Zhou DF, Zhang XY. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: Association with dyskinetic movements. Schizophr. Res. 2005 74 : 263 270.
-
(2005)
Schizophr. Res.
, vol.74
, pp. 263-270
-
-
Tan, Y.L.1
Zhou, D.F.2
Zhang, X.Y.3
-
17
-
-
0033515699
-
Sustained phosphorylation and activation of protein kinase B correlates with brain-derived neurotrophic factor and insulin stimulated survival of cerebellar granule cells
-
Foulstone EJ, Tavare JM, Gunn-Moore FJ. Sustained phosphorylation and activation of protein kinase B correlates with brain-derived neurotrophic factor and insulin stimulated survival of cerebellar granule cells. Neurosci. Lett. 1999 264 : 125 128.
-
(1999)
Neurosci. Lett.
, vol.264
, pp. 125-128
-
-
Foulstone, E.J.1
Tavare, J.M.2
Gunn-Moore, F.J.3
-
18
-
-
0036310511
-
BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents
-
Mai L, Jope RS, Li X. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J. Neurochem. 2002 82 : 75 83.
-
(2002)
J. Neurochem.
, vol.82
, pp. 75-83
-
-
Mai, L.1
Jope, R.S.2
Li, X.3
-
19
-
-
0033198715
-
Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter
-
Lau KF, Miller CC, Anderton BH, Shaw PC. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Genomics 1999 60 : 121 128.
-
(1999)
Genomics
, vol.60
, pp. 121-128
-
-
Lau, K.F.1
Miller, C.C.2
Anderton, B.H.3
Shaw, P.C.4
-
20
-
-
0035062230
-
Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease
-
Russ C, Lovestone S, Powell JF. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease. Mol. Psychiatry 2001 6 : 320 324.
-
(2001)
Mol. Psychiatry
, vol.6
, pp. 320-324
-
-
Russ, C.1
Lovestone, S.2
Powell, J.F.3
-
21
-
-
0037462449
-
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function
-
Egan MF, Kojima M, Callicott JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003 112 : 257 269.
-
(2003)
Cell
, vol.112
, pp. 257-269
-
-
Egan, M.F.1
Kojima, M.2
Callicott, J.H.3
-
22
-
-
0004085199
-
-
version 2.0 (SCID-I). New York State Psychiatric Institute, Biometrics Research. New York
-
First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders, version 2.0 (SCID-I). New York State Psychiatric Institute, Biometrics Research, New York, 1996.
-
(1996)
Structured Clinical Interview for DSM-IV Axis i Disorders
-
-
First, M.B.1
Spitzer, R.L.2
Gibbon, M.3
Williams, J.B.4
-
23
-
-
0020034360
-
Research diagnoses for tardive dyskinesia
-
Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry 1982 39 : 486 487.
-
(1982)
Arch. Gen. Psychiatry
, vol.39
, pp. 486-487
-
-
Schooler, N.R.1
Kane, J.M.2
-
24
-
-
0037472372
-
Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder
-
Nakata K, Ujike H, Sakai A et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci. Lett. 2003 337 : 17 20.
-
(2003)
Neurosci. Lett.
, vol.337
, pp. 17-20
-
-
Nakata, K.1
Ujike, H.2
Sakai, A.3
-
25
-
-
0346023025
-
A single nucleotide polymorphism in glycogen synthase kinase 3-β promoter gene influences onset of illness in patients affected by bipolar disorder
-
DOI 10.1016/j.neulet.2003.10.021
-
Benedetti F, Bernasconi A, Lorenzi C et al. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci. Lett. 2004 355 : 37 40. (Pubitemid 38077179)
-
(2004)
Neuroscience Letters
, vol.355
, Issue.1-2
, pp. 37-40
-
-
Benedetti, F.1
Bernasconi, A.2
Lorenzi, C.3
Pontiggia, A.4
Serretti, A.5
Colombo, C.6
Smeraldi, E.7
-
26
-
-
12344281670
-
Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients
-
Liou YJ, Liao DL, Chen JY et al. Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med. 2004 5 : 243 251.
-
(2004)
Neuromolecular Med.
, vol.5
, pp. 243-251
-
-
Liou, Y.J.1
Liao, D.L.2
Chen, J.Y.3
-
27
-
-
33947235663
-
Brain-derived neurotrophic factor Val66Met and psychiatric disorders: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia
-
Gratacòs M, González JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 2007 61 : 911 922.
-
(2007)
Biol. Psychiatry
, vol.61
, pp. 911-922
-
-
Gratacòs, M.1
González, J.R.2
Mercader, J.M.3
De Cid, R.4
Urretavizcaya, M.5
Estivill, X.6
-
28
-
-
34147130914
-
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression
-
Frodl T, Schüle C, Schmitt G et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 2007 64 : 410 416.
-
(2007)
Arch. Gen. Psychiatry
, vol.64
, pp. 410-416
-
-
Frodl, T.1
Schüle, C.2
Schmitt, G.3
-
29
-
-
27644551826
-
Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar i disorder
-
Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH. Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005 139B : 51 53.
-
(2005)
Am. J. Med. Genet. B Neuropsychiatr. Genet.
, vol.139
, pp. 51-53
-
-
Lohoff, F.W.1
Sander, T.2
Ferraro, T.N.3
Dahl, J.P.4
Gallinat, J.5
Berrettini, W.H.6
-
30
-
-
14644389398
-
Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum
-
Alimohamad H, Rajakumar N, Seah YH, Rushlow W. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol. Psychiatry 2005 57 : 533 542.
-
(2005)
Biol. Psychiatry
, vol.57
, pp. 533-542
-
-
Alimohamad, H.1
Rajakumar, N.2
Seah, Y.H.3
Rushlow, W.4
-
31
-
-
13444269371
-
Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP
-
Benedetti F, Serretti A, Pontiggia A et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Neurosci. Lett. 2005 376 : 51 55.
-
(2005)
Neurosci. Lett.
, vol.376
, pp. 51-55
-
-
Benedetti, F.1
Serretti, A.2
Pontiggia, A.3
-
32
-
-
35848951872
-
Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism
-
Adli M, Hollinde DL, Stamm T et al. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Biol. Psychiatry 2007 62 : 1295 1302.
-
(2007)
Biol. Psychiatry
, vol.62
, pp. 1295-1302
-
-
Adli, M.1
Hollinde, D.L.2
Stamm, T.3
-
33
-
-
4444350746
-
A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression
-
DOI 10.1016/j.neulet.2004.06.050, PII S030439400400789X
-
Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci. Lett. 2004 368 : 123 126. (Pubitemid 39194855)
-
(2004)
Neuroscience Letters
, vol.368
, Issue.2
, pp. 123-126
-
-
Benedetti, F.1
Serretti, A.2
Colombo, C.3
Lorenzi, C.4
Tubazio, V.5
Smeraldi, E.6
-
34
-
-
33645720958
-
Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease
-
Mateo I, Infante J, Llorca J, Rodríguez E, Berciano J, Combarros O. Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2006 21 : 228 232.
-
(2006)
Dement. Geriatr. Cogn. Disord.
, vol.21
, pp. 228-232
-
-
Mateo, I.1
Infante, J.2
Llorca, J.3
Rodríguez, E.4
Berciano, J.5
Combarros, O.6
-
35
-
-
0036310511
-
BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents
-
Mai L, Jope RS, Li X. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J. Neurochem. 2002 82 : 75 83.
-
(2002)
J. Neurochem.
, vol.82
, pp. 75-83
-
-
Mai, L.1
Jope, R.S.2
Li, X.3
|